Back

Fundamentals II: Advancing Therapy in HR-Positive/ HER2-Negative Metastatic Breast Cancer

In this certified on-demand micro webcast, discover the latest targeted therapy options for patients with HR-positive/HER2-negative metastatic breast cancer and hear expert discussion of personalized treatment approaches for the first line and beyond.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

IPCE CreditsUp to 0.75 creditsAAPA Category 1 Credit™Up to 0.75 creditsNursingUp to 0.75 credits

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • On-demand / recorded video
  • Credit · Up to 0.75 credits
  • Commercial Support
  • Released
    May 12, 2026
  • Last day to claim credit
    Nov 12, 2026 5 weeks left